Inhibikase Therapeutics, Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2024 | 8.78x | $0.09 | $0.81 |
| Sep 2025 | 16.08x | $0.12 | $1.97 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Dec 2024 | 8.78x | $0.09 | $0.81 |
| Sep 2025 | 16.08x | $0.12 | $1.97 |